Janux TherapeuticsJANX

那斯達克 · USD
15.14
+1.87
(+14.09%)
收盤 01/23 04:59 (UTC+8)
盤後 
15.14 
15.14 
(0.00%)
01/23 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.01
  • 0.03
  • 0.02
  • 0.01
  • 0.09
  • 0.00
  • -
  • -
  • -
  • 0.10
icon
  • -48.39
  • 138.13
  • -2.22
  • -49.13
  • 610.62
  • -95.07
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
10,000
-
-
-
439
8,897
1,252
2,461
2,517
1,057
營業成本
----------
營業毛利
10,000
-
-
-
439
8,897
1,252
2,461
2,517
1,057
營業費用
45,25145,11834,89729,02236,281-21,41318,59818,33021,805
研發費用
34,62934,66425,05520,80618,61414,89814,07012,24111,89214,924
推銷及管理費用
10,62210,4549,8428,21617,6677,8217,3436,3576,4386,881
非經常性項目費用
----------
其他營業費用
----------
營業利益
-35,251
-45,118
-34,897
-29,022
-35,842
-13,822
-20,161
-16,137
-15,813
-20,748
其他收入及費用
10,93811,26011,3898,8067,7837,8635,4014,3794,2453,240
利息費用
----------
稅前純益
-24,313
-33,858
-23,508
-20,216
-28,059
-5,959
-14,760
-11,758
-11,568
-17,508
所得稅
----------
稅後純益
-24,313
-33,858
-23,508
-20,216
-28,059
-5,959
-14,760
-11,758
-11,568
-17,508
基本每股稅後盈餘(元)
-0.39-0.55-0.38-0.36-0.51-0.11-0.30--0.25-0.42
稀釋每股稅後盈餘(元)
-0.39-0.55-0.38-0.35-0.53-0.10-0.30-0.24-0.24-0.42
基本平均股數(千股)
62023.0061902.0061791.0056832.0054628.0054451.0049049.00-45708.0041836.00
稀釋平均股數(千股)
62023.0061902.0061791.0056832.0054628.0054451.0049049.00-45708.0041836.00
還原基本每股稅後盈餘(元)
-0.39-0.55-0.38-0.36-0.51-0.11-0.30--0.25-0.42
還原稀釋每股稅後盈餘(元)
-0.39-0.55-0.38-0.35-0.53-0.10-0.30-0.24-0.24-0.42
還原基本平均股數(千股)
62,02361,90261,79156,83254,62854,45149,049-45,70841,836
還原稀釋平均股數(千股)
62,02361,90261,79156,83254,62854,45149,049-45,70841,836
EBITDA(千元)
-28,435-38,523-27,210-22,631-30,447-8,426-16,015-13,288-13,176-18,878

大家都在看

HOT